DNA binding of tamoxifen and its analogues:: identification of the tamoxifen-DNA adducts in rat liver

被引:16
作者
Rajaniemi, H [1 ]
Koskinen, M
Mäntylä, E
Hemminki, K
机构
[1] Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden
[2] Orion Corp, Biochem Toxicol Unit, Turku 20101, Finland
关键词
tamoxifen; breast cancer; DNA adducts; P-32-postlabelling; risk assessment;
D O I
10.1016/S0378-4274(98)00338-5
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
DNA binding of tamoxifen and some structurally-related drugs (toremifene, clomiphene, triparanol and raloxifene) in rat liver was studied using the P-32-postlabelling method. As only tamoxifen was shown to form high levels of DNA adducts, the identity of these adducts was studied. Recently, we have identified by mass spectroscopy the two main tamoxifen adducts in rat liver DNA as the N-desmethyltamoxifen and tamoxifen adducts of N-2-deoxyguanosine in which the linkage is through alpha-carbon in the tamoxifen structure. Minor adducts were identical to different diastereomers of alpha-(N-2-deoxyguanosinyl)tamoxifen and of alpha-(N-6-deoxyadenosinyl)tamoxifen. Altogether these adducts accounted for at least 95% of adducts formed in vivo, implicating that the alpha-hydroxylation of the ethyl group is the major activation pathway for DNA adducts. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:453 / 457
页数:5
相关论文
共 11 条
  • [1] [Anonymous], 1996, IARC Monogr Eval Carcinog Risks Hum, V66, P253
  • [2] Buzdar AU, 1998, CLIN CANCER RES, V4, P527
  • [3] The metabolic activation of tamoxifen and α-hydroxytamoxifen to DNA-binding species in rat hepatocytes proceeds via sulphation
    Davis, W
    Venitt, S
    Phillips, DH
    [J]. CARCINOGENESIS, 1998, 19 (05) : 861 - 866
  • [4] Tamoxifen: Teaching an old drug new tricks?
    Grainger, DJ
    Metcalfe, JC
    [J]. NATURE MEDICINE, 1996, 2 (04) : 381 - 385
  • [5] TAMOXIFEN AND THE INDUCTION OF CANCER
    KING, CM
    [J]. CARCINOGENESIS, 1995, 16 (07) : 1449 - 1454
  • [6] MANI C, 1993, DRUG METAB DISPOS, V21, P645
  • [7] Osborne MR, 1996, CANCER RES, V56, P66
  • [8] POON GK, 1993, DRUG METAB DISPOS, V21, P1119
  • [9] DNA adduct-formation by tamoxifen and structurally-related compounds in rat liver
    Rajaniemi, H
    Mäntylä, E
    Hemminki, K
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 1998, 113 (02) : 145 - 159
  • [10] RAJANIEMI H, 1998, IN RPESS CARCINOGENE